Insights & Discussion
Pomegranate extract supplements can help improve clinical symptoms and lower blood cell counts associated with inflammation in patients with allergic asthma.
In this study, 64 participants with mild to moderate allergic asthma were randomly divided into two groups: a control group which was given placebo capsules and an intervention group which was given pomegranate extract capsules. The intervention group was administered a dosage of 250 milligrams of pomegranate extract twice daily over a period of eight weeks. The clinical symptoms and blood cell counts of all the participants were measured before starting the intervention and post the completion of it.
The results of the study indicated that the group which was given pomegranate extract exhibited considerable improvement in clinical symptoms like shortness of breath and restrictions on activity, as compared to the control group. Additionally, the participants in the intervention group displayed a substantive drop in eosinophil, basophil, and neutrophil counts. Notably, there was a statistically significant difference in the neutrophil and eosinophil levels between the two groups, which suggests that pomegranate extract supplementation might have potential therapeutic benefits for asthma patients.
Discover Related Insights
Pomegranate juice supplementation has been found to effectively decrease testosterone levels in overweight and obese women diagnosed with polycystic ovary syndrome.
2023 Phytotherapy Research The effect of concentrated pomegranate juice on biomarkers of inflammation, oxidative stress, and sex hormones in overweight and obese women with polycystic ovary syndrome: A randomized controlled trial Abedini M, Ramezani‐Jolfaie N, Ghasemi‐Tehrani H, Tarrahi MJ, Amani R
Randomised Controlled Trial Pomegranate Testosterone
In the methodology, the study employed a randomized controlled trial which involved 44 participants. The women, aged between 18 and 40 years, had all been diagnosed with polycystic ovary syndrome and had a body mass index exceeding 25 kg/m. They were randomly divided, with one group consuming 45 ml/day of concentrated pomegranate juice and the other group receiving no intervention. A variety of biomarkers for sex hormones, inflammation, and oxidative stress were measured before starting the trial and again after eight weeks.
Further discussion of the results revealed a significant decrease in testosterone levels among the overweight and obese women with polycystic ovary syndrome who took concentrated pomegranate juice over the eight week period, in contrast to those in the control group. Apart from testosterone, no significant changes were observed for luteinizing hormone, sex hormone-binding globulin levels or for markers of inflammation and oxidative stress between the two groups.
Pomegranate can significantly enhance women's health during and after menopause by reducing hot flashes severity and other menopause symptoms.
2023 Phytotherapy Research Pomegranate effects on the health aspects of women during peri‐ and postmenopause: A systematic review and meta‐analysis Moeini R, Shirafkan H, Gorji N
Systematic Review Hot Flushes Pomegranate
The study aimed at understanding the impacts of pomegranate on women's health through and following menopause. To gather data, a rigorous search was conducted on various academic platforms, including PubMed, Web of Science, Cochrane, Scopus, and Google Scholar, up to the end of 2022. All forms of clinical research studies, from randomized clinical trials to case series, were considered for review. The material was evaluated using the Cochrane RoB 2.0 tool specifically for quality assessment of randomized clinical trials. To quantify the effects of the pomegranate intervention, standardized mean differences were calculated using a random effect model.
It was found that pomegranate significantly reduces the severity of hot flashes in menopausal women, improves their high-density lipoprotein levels, and reduces the Follicle-Stimulating Hormone (FSH). However, no significant improvement was noticed in the low-density lipoprotein, body mass index, and body weight. Despite these findings, the study recognized that the results' conclusiveness was hampered due to small sample sizes and the lack of study design elements such as blinding and randomization.
Pomegranate and its active components can protect against natural and chemical toxic agents, impacting mechanisms such as oxidative stress, inflammation, apoptosis, and liver or cardiac function regulation.
2023 Phytomedicine Protective effects of pomegranate (Punica granatum) and its main components against natural and chemical toxic agents: A comprehensive review Hosseini A, Razavi BM, Hosseinzadeh H
Review Article Oxidative Stress Pomegranate
This paper is a review of various in vivo and in vitro studies focusing on pomegranate (Punica granatum) and its active components, including ellagic acid and punicalagin, and their protective effects against toxic substances. The articles were sourced from multiple databases like Web of Sciences, Google Scholar, PubMed, and Scopus spanning all available time periods until the end of September 2022.
The research indicates that pomegranate and its constituents have showcased protective effects against both natural toxins, such as aflatoxins and endotoxins, and chemical toxicants like arsenic, diazinon, and carbon tetrachloride. This protection is attributed to the preventive mechanisms activated against oxidative stress, reduction of key inflammatory mediators, modulation of apoptosis, and signaling pathways associated with cellular growth. Additionally, these components appear to aid in the improvement of liver and cardiac function through the regulation of key enzymes.
M
Pomegranate juice extract may reduce the damage to the endometrium in Polycystic ovary syndrome through its antioxidant, anti-inflammatory, anti-fibrotic, and anti-proliferative effects.
2022 Morphologie Role of pomegranate extract in restoring endometrial androgen receptor expression, proliferation, and pinopodes in a rat model of polycystic ovary syndrome Ibrahim MAA, Sadek MT, Sharaf Eldin HEM
Experimental Study Endometrium Pomegranate
To test the possible benefits of pomegranate juice extract (PJE) on endometrial injury in Polycystic ovary syndrome (PCOS), forty adult albino rats were divided into four groups, control, PJE-treated, letrozole-treated (PCOS), and PJE & PCOS groups. The respective treatments were administered for a duration of three weeks. Serum and tissue samples were assayed for Follicle-stimulating hormone, Luteinizing hormone, testosterone, estradiol, and malondialdehyde. Uterine samples were also tested using a range of histological staining techniques and a scanning electron microscope.
In the rat model of PCOS, significant increases in certain biochemical indicators in serum samples were observed while uterine sections showed numerous alterations to the endometrium, signs of inflammation and an increase in the endometrial collagen fiber content. Additionally, there was increased expression of certain immunohistochemical staining markers and a decrease in the mean number of pinopodes observed through scanning electron microscopy. However, these various potentially harmful biochemical, histological and immunohistochemical alterations were efficiently reduced with the administration of PJE. This points towards the potential benefits of PJE in addressing and potentially reducing endometrial injury associated with PCOS.
Ellagic acid, found naturally in pomegranates, significantly inhibits growth and migration of gastric cancer cells without causing notable side effects.
2022 Human & Experimental Toxicology The effects of ellagic acid and other pomegranate (Punica granatum L.) derivatives on human gastric cancer AGS cells Cheshomi H, Bahrami AR, Rafatpanah H, Matin MM
Experimental Study Ellagic Acid Pomegranate Stomach Cancer
In the methodology of this study, High Performance Liquid Chromatography (HPLC) was employed to detect the presence of Ellagic Acid (EA) in samples. Various methods were then used to determine the various anti-cancer properties of different concentrations of pomegranate fruit juice, pomegranate peel extract, and pure EA. This included an MTT assay, apoptosis and scratch assay, gelatin zymography and quantitative RT-PCR. Additionally, the study examined the impact of these compounds on immunocompromised C57BL/6 mice carrying human gastric cancer tumors.
Extending to discussing the results, it was found that EA inhibited both the proliferation and migration of gastric cancer cells in mice and altered gene expressions related to apoptosis and inflammation. The treatments with EA or pomegranate extract resulted in a noticeable decrease in tumor size in the lab mice. No significant side effects were reported from EA use. In sum, the results showed EA's potential as a safe and effective anti-cancer agent specific to gastric adenocarcinoma.
Sign In
Users not signed in are limited to viewing the 5 most recent items of content.